ARCHIVES

NCAB Can’t Decide Fate of Women’s Health Trial, Forces It Back Into Lap of DCPC Scientific Advisors

This article is from The Cancer Letter archive.

Vol. 13 No. 38 | October 2, 1987

Download PDF Visit The Full Archive

Related Articles

Professional Societies: AACR Presents Awards At Annual Meeting

April 18, 1997

FDA Approves Lilly’s Alimta For Metastatic NSCLC

August 27, 2004

FDA’s Jane Henney

February 11, 1994

FDA Auditors Spend Two Weeks At Duke, Nevins Loses Position in Reorganization

January 28, 2011

In Brief: Pitot Appointed To Cancer Panel, Replacing Jako; Fisher, Wattenberg, Curtiss Lead Cancer Groups

May 29, 1992

Cancer Rates May Rise 50% By 2020, IARC Says

April 18, 2003